arthritis

News

$refractory chronic gout$

Sobi starts rolling FDA filing for chronic gout drug

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to cu

News

FDA approves Ironwood's gout combination drug

Good news for Ironwood, which forecast annual sales of up to $300m, despite black box kidney failure warning.

News

Otezla gains NICE approval for psoriatic arthritis

Earlier decision to reject drug reversed.

UK & Europe

NICE says Otezla's bargain price offsets lower efficacy

Otezla cheap and convenient, but less effective than rivals, says NICE.

News

one of many. Many of the same bottle, with a focus on one of them.

Janssen's RA candidate among hot topics at EULAR

But attendees warned to expect "oceanic" weather.

Sobi starts rolling FDA filing for chronic gout drug

FDA approves Ironwood's gout combination drug

Otezla gains NICE approval for psoriatic arthritis

NICE says Otezla's bargain price offsets lower efficacy

Janssen's RA candidate among hot topics at EULAR

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

arthritis

Editor's Picks